There have been enough next-generation sequencing (NGS) launches this year—both products and companies—to make even genomics’ aficionados heads spin. However, Pacific Biosciences (PacBio)—known for ...
MENLO PARK, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the Vega™ system, the company’s first ...
PacBio (PACB), a leading developer of high-quality, highly accurate genomic sequencing solutions, today announced the inclusion of the Onso short-read sequencing platform in the 10x Genomics ...
When GEN spoke with Christian Henry, CEO of PacBio, before last year’s American Society of Human Genetics (ASHG) conference being held in Los Angeles, his excitement was palpable. The company was ...
Recent announcements are likely better news for 10x Genomics and Twist Bioscience than for the DNA-sequencing pioneer. Pacific Biosciences (PACB) is having a solid month. Shares of the DNA-sequencing ...
The genomics company PacBio isn’t making much progress in the most important source of revenue. Investing in lab-hardware companies is easy. That’s primarily because most genomics stocks hailing from ...
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued focus on research and development. The optimism, led by decent second-quarter 2024 earnings ...
Pacific Biosciences of California (PacBio) PACB shares are trading higher today after the company announced it received orders for 76 Revio systems in the fourth quarter of 2022. The company also ...
Vega is designed to make HiFi long-read sequencing more affordable and accessible to a broader range of researchers, helping them unlock new long-read sequencing applications. Vega offers the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback